IMUX's three largest insider shareholders as of September 29, 2026 are Daniel Vitt (President And Ceo, 977 shares), Andreas Muehler (Chief Medical Officer, 745 shares), Richard Alan Rudick (Director, 576 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Andreas Muehler | Chief Medical Officer | 745 | 0 | 745 | 33.1% | 16 May, 2022 |
| 2 | Richard Alan Rudick | Director | 576 | 0 | 576 | 25.6% | 04 Jun, 2025 |
| 3 | Joerg Neermann | Director | 500 | 0 | 500 | 22.2% | 05 Jun, 2025 |
| 4 | Glenn Whaley | Chief Financial Officer | 239 | 0 | 239 | 10.6% | 04 Jun, 2025 |
| 5 | Duane Nash | Executive Chairman | 90 | 0 | 90 | 4.0% | 16 Jun, 2025 |
| 6 | Daniel Vitt | Ceo And Director | 73 | 0 | 73 | 3.2% | 20 Jun, 2025 |
| 7 | Jason Tardio | President And Coo | 31 | 0 | 31 | 1.4% | 20 Jun, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 16 Sep, 2026 | Robert Thorvald Nagel | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 16 Sep, 2026 | Partners L P/Il Bvf | Director, Other | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Indirect |
| 06 Aug, 2026 | Elena Ridloff | Director | Acquired A | 50,740 | $0.00 | $0 | 50,740 | Direct |
| 05 Jul, 2026 | Joerg Neermann | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 05 Jul, 2026 | Simona Skerjanec | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 05 Jul, 2026 | Barclay A Phillips | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 05 Jul, 2026 | Jon Congleton | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 05 Jul, 2026 | Richard Alan Rudick | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Joerg Neermann | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Michael W Bonney | Director | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 29 Jun, 2026 | Daniel Vitt | Director | Acquired A | 445,000 | $0.00 | $0 | 445,000 | Direct |
| 29 Jun, 2026 | Simona Skerjanec | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Glenn Whaley | Chief Financial Officer | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |
| 29 Jun, 2026 | Jason Tardio | President And Coo | Acquired A | 253,000 | $0.00 | $0 | 253,000 | Direct |
| 29 Jun, 2026 | Jon Congleton | Director | Acquired A | 50,740 | $0.00 | $0 | 50,740 | Direct |
| 29 Jun, 2026 | Richard Alan Rudick | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Tamar D Howson | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Barclay A Phillips | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 22 May, 2026 | Erik Lundgren | Chief Executive Officer | Acquired A | 1,000,000 | $0.00 | $0 | 1,000,000 | Direct |
| 24 Apr, 2026 | Michael A. Panzara | Chief Medical Officer | Acquired A | 300,000 | $0.00 | $0 | 750 | Direct |